Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
June 20, 2022
Polish patients and physicians will soon be able to benefit from Hemolens Diagnostics groundbreaking non-invasive solutions for the diagnosis of coronary heart disease.
What are the advantages of our technology?
Cardiolens FFR-CT Pro® diagnostics is a completely non-invasive anatomical and functional diagnosis of the coronary arteries, which can be performed on an outpatient basis (no hospitalization required). It carries no risk of side effects or complications e.g. associated with invasive diagnostics.
The use of computational fluid dynamics, provides full diagnostic precision, while maintaining personalized patient outcomes. Our technology, supports physicians in making optimal therapeutic decisions for the patient and reduces the risk of error.
Hemolens Diagnostics solutions have virtually no limits to further technological development. We believe that our diagnostic methods dedicated to vascular diseases have the potential to become the “gold standard” worldwide, not only in cardiology but also in other fields such as oncology, pulmonology, angiology and neurology.
Intended Use:
Cardiolens FFR-CT Pro is a coronary physiologic simulation software for the clinical quantitative and qualitative analysis of previously acquired Coronary Computed Tomography Angiography (CCTA) and optionally with Continuous Non-invasive Blood Pressure (CNBP) data for assessment of patients with suspected Chronic Coronary Syndromes (CCS). It provides hemodynamic diagnostic factor FFR-CT (Fractional Flow Reserve with Computed Tomography), a mathematically derived quantity, computed from simulated pressure, velocity and blood flow information obtained from a 3D computer model generated from static coronary CT images and optionally from CNBP measurement. The factor FFR-CT at the output of Cardiolens FFR-CT Pro device is intended to support the functional evaluation of coronary artery disease. The Cardiolens FFR-CT Pro outputs are provided to support qualified clinicians to aid in the evaluation and assessment of coronary arteries. The results of Cardiolens FFR-CT Pro are intended to be used by qualified clinicians in conjunction with the patient’s clinical history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgment.